Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)
Active, not recruiting · NCT03477500 · Registry updated 2025-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS) | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2025-06-25 | NCT03477500 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haukeland University Hospital | 163 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akademiska Sjukhuset | Uppsala | Sweden | 20 |
| Akershus University Hospital | Oslo | Norway | 11 |
| Haukeland University Hospital | Bergen | Norway | 52 |
| Rigshospitalet | Copenhagen | Denmark | 84 |
| Sahlgrenska University Hospital | Gothenburg | Sweden | 96 |
| St. Olav's University Hospital | Trondheim | Norway | 1 |
| University Hospital of North Norway | Tromsø | Norway | 18 |
| VUmc | Amsterdam | Netherlands | 2 |